Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
PioLigOn logo — Platform for designing peptide drugs.

PioLigOn

Platform for designing peptide drugs.

Founded 2020 Poland Poland 2 employees Grant Total: $320.00K Biotechnology

General Information

Company Name PioLigOn
Founded Year 2020
Location Poland Poland +1
Employees 2
Industries Biotechnology
Funding Stage Grant
Social

Get notified when PioLigOn moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PioLigOn

PioLigOn is a biotechnology startup, established in 2020, headquartered in Poland. The company's slogan, "Platform for designing peptide drugs," underscores its commitment to revolutionizing drug discovery. Their flagship product, VPDesigner42™, offers a cutting-edge approach to drug development, harnessing the latest advancements in computational de novo peptide design and unnatural peptide synthesis. The startup received a significant boost with a $270.00K grant investment on 16 April 2021. This strategic funding is poised to propel PioLigOn's innovative solutions to the forefront of the biotechnology industry. As a venture capitalist, this presents a compelling opportunity to engage with a groundbreaking company that is at the vanguard of peptide drug design and development.

Taxonomy: Peptide drug design, Drug discovery platform, Computational de novo design, Unnatural peptide synthesis, Computational methods, Unnatural amino acids, Biologics, Small molecule drugs, Targeted drug design, Drug candidates, Undruggable targets

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 16 Apr 2021
Grant •••••• - 21 May 2020

PioLigOn Alternatives & Competitors

PioLigOn vs
Amide Technologies
Amide Technologies United States

Peptide sourcing shouldn't stand in the way of discovery

Series A
9 employees
Information Technology
PioLigOn vs
Perpetual Medicines
Perpetual Medicines

AI-powered computational platform for peptide drug discovery

Acquired
2 employees
Biotechnology
PioLigOn vs
Pinnacle Medicines
Pinnacle Medicines

Transforming patients’ lives with oral peptides

Series B
21 employees
Biotechnology

FAQ About PioLigOn

Platform for designing peptide drugs.
PioLigOn was founded in 2020.
PioLigOn is headquartered in Poland.
PioLigOn operates in the following industries: Biotechnology.
PioLigOn has approximately 2 employees.
PioLigOn has completed 2 funding rounds, raising a total of $320.00K. The latest funding stage is Grant.
Top alternatives and competitors to PioLigOn include Amide Technologies, Perpetual Medicines, Pinnacle Medicines, GaloreTx Pharmaceuticals Private Limited, CPC Scientific Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PioLigOn and Amide Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PioLigOn and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy